Strategic Blueprint’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-635
Closed -$63K 468
2019
Q3
$63K Buy
+635
New +$60.3K 0.05% 133

Other funds holding CELG

Strategic Blueprint's CELG Position: Q4 2019 in Review

Strategic Blueprint sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 635 shares — an estimated $63K sold.

Strategic Blueprint first reported a position in CELG in Q3 2019 and held it in 1 quarter. The position peaked at $63K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Strategic Blueprint reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Strategic Blueprint sold 635 Celgene Corp shares in Q4 2019, an estimated $63K.
  • Strategic Blueprint first reported a position in Celgene Corp in Q3 2019 and held it in 1 quarter.
  • Strategic Blueprint's Celgene Corp position peaked at $63K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Strategic Blueprint's 13F filing for Q4 2019, filed 10 Jan 2020.